Understanding Your Switch Options: Wegovy vs Mounjaro
Can I Switch From Wegovy to Mounjaro: Key Mechanism Differences
When considering whether you can switch from Wegovy to Mounjaro, understanding the fundamental differences between these prescription-only medicines is essential. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics natural fullness hormones, while Mounjaro uses tirzepatide, which targets both GIP and GLP-1 receptors in a dual mechanism approach. Both medications are designed to support weight management alongside a reduced-calorie diet and increased physical activity, but their different pathways may suit different patients.
The starter dosing approaches also differ significantly between these treatments. Wegovy begins with a structured 0.25mg dose for weeks 1-4, followed by gradual escalation through 0.5mg, 1mg, 1.7mg, reaching the maintenance dose of 2.4mg by week 17. Mounjaro follows its own escalation pattern, starting at 2.5mg and increasing to 5mg, 7.5mg, 10mg, and potentially 15mg. Your prescriber at EverydayMeds can evaluate which starting approach aligns better with your tolerance and treatment goals when you're considering making this switch.
Wegovy Starter Dose Pricing and Switch Considerations
For patients asking "can I switch from Wegovy to Mounjaro," cost comparison is often a significant factor in the decision-making process. Wegovy's starter dose of 0.25mg is available at EverydayMeds for £79.99, representing the beginning of a proven escalation schedule. Our Intro Duo bundle combines the 0.25mg starter with the 0.5mg second month dose for £169.99, providing convenient continuity for your initial treatment period. New customers can apply discount code FIRST40 at checkout, while returning customers benefit from code DOSE25.
The complete Wegovy escalation journey involves structured pricing: 0.5mg at £94.99 (weeks 5-8), 1mg at £99.99 (weeks 9-12), 1.7mg at £139.99 (weeks 13-16), and the maintenance 2.4mg dose at £209.99 for week 17 onwards. This transparent pricing structure allows you to plan your treatment costs effectively when comparing your options. Both Wegovy and Mounjaro are available from EverydayMeds, ensuring you have access to expert prescriber guidance regardless of which direction your treatment decision takes you.
Clinical Evidence for Patients Switching From Wegovy to Mounjaro
When evaluating whether you can switch from Wegovy to Mounjaro, clinical trial data provides important context for informed decision-making. The STEP trials demonstrated that patients taking Wegovy alongside diet and exercise achieved an average weight loss of approximately 15% at 68 weeks in STEP 1, with sustained results of 15.2% at 2 years in STEP 5 (Wilding et al., NEJM, 2021). Additionally, the SELECT cardiovascular outcomes trial showed a 20% reduction in major cardiovascular events, highlighting potential broader health benefits.
Mounjaro's SURMOUNT trials showed their own outcomes with the dual GIP and GLP-1 mechanism, though direct head-to-head comparisons aren't available due to different trial designs and populations. Both medications may help support significant weight management when used as prescribed, but individual responses can vary considerably. Your prescriber will consider your specific medical history, current treatment response, and individual circumstances when discussing whether switching between these prescription-only medicines is appropriate for your situation.
How Wegovy Works: Understanding the GLP-1 Mechanism
For patients considering whether they can switch from Wegovy to Mounjaro, understanding Wegovy's specific mechanism helps clarify potential differences in treatment experience. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the action of natural incretin hormones produced in your intestine. This mechanism may help reduce appetite by acting on brain centres that control hunger and satiety, potentially leading to smaller portion sizes and reduced food cravings between meals. The medication is designed to slow gastric emptying, which can contribute to prolonged feelings of fullness after eating. Additionally, GLP-1 receptor activation may influence glucose-dependent insulin secretion, though Wegovy is specifically licensed for weight management rather than diabetes treatment.
Ordering Process When Switching Treatment Options
Whether you're continuing with Wegovy or considering a switch to Mounjaro, EverydayMeds streamlines the prescription process through our comprehensive clinical assessment system. The 3-minute online assessment captures your medical history, current medications, treatment goals, and relevant health conditions to support prescriber decision-making. Our qualified prescribers, operating under GPhC registration #9012878, typically complete reviews within 3 working days, with express 24-hour options available when clinically appropriate. Once your prescription is approved, next-day delivery ensures you receive your medication via temperature-controlled cold-chain transport. This reliable process maintains the same high standard whether you're starting Wegovy's 0.25mg dose or transitioning to alternative treatments under professional guidance.
Storage and Practical Considerations for Treatment Switching
When evaluating whether you can switch from Wegovy to Mounjaro, practical storage requirements often influence patient preferences and treatment adherence. Wegovy offers superior storage flexibility, maintaining stability for up to 6 weeks at room temperature below 30°C once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. This advantage proves particularly valuable for travel, work schedules, or situations where consistent refrigeration access is challenging. Both medications require refrigerated storage at 2-8°C before first use, and both utilise pre-filled pen injection systems, though the specific pen designs differ. The Wegovy FlexTouch pen system provides familiar, user-friendly administration with clear dose indicators and safety features. Understanding these practical aspects helps ensure successful treatment continuation regardless of which option you and your prescriber ultimately choose.
Starter Dose Escalation: Why You Can't Switch Directly to Higher Doses
A crucial consideration when asking "can I switch from Wegovy to Mounjaro" involves understanding that dose escalation cannot be bypassed, regardless of your previous treatment experience. Even if you've been on maintenance doses of one medication, switching to the other typically requires starting at their respective starter doses to assess tolerance and minimise side effects. Wegovy's 0.25mg starter dose serves essential safety and tolerability functions, allowing your body to adapt to the GLP-1 mechanism gradually over the first month. This controlled approach helps reduce the likelihood of gastrointestinal side effects such as nausea, which are most common during treatment initiation.
The structured escalation schedule isn't merely a cautious approach – it's a clinically validated protocol that optimises both safety and effectiveness outcomes. Attempting to skip starter doses or accelerate the timeline can increase discontinuation rates due to tolerability issues, potentially undermining your long-term treatment success. Your prescriber will evaluate your individual circumstances, including any previous treatment experience, but the fundamental principle of gradual dose escalation remains consistent across both Wegovy and Mounjaro protocols.
Begin Your Treatment Journey: Wegovy Starter Options Available
Ready to start your Wegovy journey or discuss switching options? EverydayMeds provides comprehensive support for both new patients and those considering treatment changes under professional supervision. Our Wegovy 0.25mg starter dose at £79.99 represents the evidence-based beginning of proven weight management support, while our Intro Duo bundle offers convenient two-month starter coverage for £169.99. Remember to apply discount code FIRST40 at checkout for new customers, or DOSE25 for returning customers. Complete your clinical assessment today, and our qualified prescribers will evaluate whether Wegovy starter dosing aligns with your treatment goals and medical profile. Both Wegovy and Mounjaro remain available options at EverydayMeds, ensuring you receive expert guidance in selecting the most appropriate treatment path for your individual needs.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
